616 A novel non-covalent linker peptide with nanomolar affinity for clinical IgG1 antibodies preserves antibody-antigen affinity and drug potency against PDL1+ melanoma when conjugated with DM1
Svetomir Markovic, John Butterfield, Shari Sutor and 1 more
Journal for ImmunoTherapy of Cancer · 2020
doi:10.1136/jitc-2020-sitc2020.0616 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References5
5 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.